Search For "remdesivir"
COVID-19: Pharma giants seek DCGI's approval to manufacture, sell Remdesiv
Updated : 5 years, 9 months ago IST
New Delhi [India], June 4 (ANI): Two domestic pharmaceutical firms--Mylan and Jubilant Life Sciences have approached the country's top drug regulator--Drug Controller General of India (DCGI) to seek its approval to manufacture and sell anti-viral drug 'Remdesivir' in India to combat COVID-19
Read More
Remdesivir approved for emergency use to treat COVID-19 patients, says Hea
Updated : 5 years, 9 months ago IST
New Delhi [India], June 2 (ANI): The Health Ministry said on Tuesday said that Remdesivir has been approved for emergency use to treat COVID-19 patients.
Read More
COVID-19: Remdesivir gets nod from CDCSO for 'restricted emergency use' on
Updated : 5 years, 9 months ago IST
New Delhi [India], June 2 (ANI): In a significant development, the country's top drug controller the Central Drug Control Standard Organisation (CDCSO) has given permission to Gilead Sciences for marketing authorization of its anti-viral drug Remdesivir "only for restricted emergency use" o
Read More
Coronavirus: Too early to discuss pricing of remdesivir, says US' Departme
Updated : 5 years, 9 months ago IST
Washington DC [USA], May 28 (ANI): The Department of Health and Human Services has said that it is too early to discuss the pricing of 'remdesivir', the drug which has raised everyone's hopes of treating the coronavirus.
Read More
'Govt still not satisfied with the efficacy of antiviral drugs Remdesivir,
Updated : 5 years, 10 months ago IST
New Delhi [India], May 15 (ANI): The Union Health Ministry is still not satisfied with the efficacy of two antiviral drugs--Remdesivir and Favipiravir--for the treatment of COVID-19 patients.
Read More
Trump administration failed to scale up in time to distribute COVID-19 dru
Updated : 5 years, 10 months ago IST
Washington DC [USA], May 15 (Sputnik/ANI): There are not enough doses of the coronavirus trial drug remdesivir because the Trump administration failed to ramp up production and lacks a distribution plan, former government vaccine developer Rick Bright said on Thursday.
Read More
Jubilant Life Sciences surges 5 pc after signing deal with Gilead for prod
Updated : 5 years, 10 months ago IST
Mumbai (Maharashtra) [India], May 13 (ANI): The share price of Jubilant Life Sciences surged 5 per cent hitting upper circuit of Rs 429.95 per share on Wednesday after the company signed a deal with US-based Gilead Sciences Inc for production of Remdesivir to fight COVID-19.
Read More
COVID-19: Cipla enters into licensing pact with Gilead to manufacture and
Updated : 5 years, 10 months ago IST
Mumbai (Maharashtra) [India], May 13 (ANI): Pharmaceutical major Cipla said on Wednesday it has signed a non-exclusive licensing agreement with Gilead Sciences Inc for manufacturing and distributing investigational medicine Remdesivir which has been issued an emergency use authorisation by t
Read More
Gilead in talks with Indian drugmakers to produce remdesivir for treatment
Updated : 5 years, 10 months ago IST
New Delhi [India], May 6 (ANI): US-based biopharmaceutical major Gilead Sciences said on Wednesday it is negotiating long-term voluntary licences with several generic drugmakers in India to produce remdesivir for developing countries.
Read More
Too early for comparisons between Hydroxychloroquine and Remdesivir in COV
Updated : 5 years, 10 months ago IST
New Delhi [India], May 5 (ANI): It is too early to say whether Hydroxychloroquine or Remdesivir works better against COVID-19, as it can be ascertained only after conducting trials, according to the Director-General (DG) of Council of Scientific and Industrial Research (CSIR), Dr Shekhar C M
Read More
Combating COVID-19: Dr Harsh Vardhan discusses progress on antibody drug -
Updated : 5 years, 10 months ago IST
New Delhi [India], May 4 (ANI): Union Health Minister Dr Harsh Vardhan on Monday discussed among other things the progress over Remdesivir -- antibody-drug recently approved by the US-FDA for emergency use to treat COVID-19 patients -- with the heads of Council of Scientific and Industria
Read More
India can easily do synthesis of antiviral drug - Remdesivir: Former ICMR
Updated : 5 years, 10 months ago IST
New Delhi [India], May 3 (ANI): India can easily do the synthesis of antiviral drug - Remdesivir - if allowed by the US-based pharma major Gilead Sciences, said Dr Nirmal K Ganguly, former Director-General, Indian Council of Medical Research (ICMR), on Saturday.
Read More